Swati Garg

Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

Stéphanie Lheureux, Mihaela Cristea, Jeffrey P. Bruce et al. · The Lancet · 2021 · 204 citations · Full text

Medicine, Metronomic Therapy, Clinical Trials +7

Sirt1 and mir‐9 expression is regulated during glucose‐stimulated insulin secretion in pancreatic β‐islets

Deepti Ramachandran, Upasana Roy, Swati Garg et al. · FEBS Journal · 2011 · 173 citations · Full text

Insulin Signaling, Sirt1 Expression, Metabolic Syndrome +17

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Daniel B. Lipka, Tania Witte, Réka Tóth et al. · Nature Communications · 2017 · 136 citations · Full text

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Stéphanie Lheureux, Ana Oaknin, Swati Garg et al. · Clinical Cancer Research · 2020 · 126 citations · Full text

Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies

Alexander Wong, Thomas J. Marrie, Swati Garg et al. · Epidemiology and Infection · 2010 · 93 citations · Full text